Verition Fund Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
Verition Fund Management's HAE Position: Q3 2026 in Review
Verition Fund Management sold out of Haemonetics (HAE) in Q3 2026, closing a stake of 105,508 shares — an estimated $7.91M sold.
Verition Fund Management first reported a position in HAE in Q4 2016 and held it in 19 quarters. The position peaked at $7.91M in Q2 2026. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.
- Verition Fund Management reported no remaining Haemonetics position as of Q3 2026 after selling out during the quarter.
- Verition Fund Management sold 105,508 Haemonetics shares in Q3 2026, an estimated $7.91M.
- Verition Fund Management first reported a position in Haemonetics in Q4 2016 and held it in 19 quarters.
- Verition Fund Management's Haemonetics position peaked at $7.91M in Q2 2026.
- 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.
Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.